These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28242713)

  • 1. Activation of Peroxisome Proliferator Activator Receptor β/δ Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus.
    Romero M; Toral M; Robles-Vera I; Sánchez M; Jiménez R; O'Valle F; Rodriguez-Nogales A; Pérez-Vizcaino F; Gálvez J; Duarte J
    Hypertension; 2017 Apr; 69(4):641-650. PubMed ID: 28242713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endoplasmic reticulum stress in the protective effects of PPARβ/δ activation on endothelial dysfunction induced by plasma from patients with lupus.
    Toral M; Jiménez R; Romero M; Robles-Vera I; Sánchez M; Salaices M; Sabio JM; Duarte J
    Arthritis Res Ther; 2017 Dec; 19(1):268. PubMed ID: 29208022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus.
    Gómez-Guzmán M; Jiménez R; Romero M; Sánchez M; Zarzuelo MJ; Gómez-Morales M; O'Valle F; López-Farré AJ; Algieri F; Gálvez J; Pérez-Vizcaino F; Sabio JM; Duarte J
    Hypertension; 2014 Aug; 64(2):330-7. PubMed ID: 24842914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity.
    Toral M; Gómez-Guzmán M; Jiménez R; Romero M; Zarzuelo MJ; Utrilla MP; Hermenegildo C; Cogolludo Á; Pérez-Vizcaíno F; Gálvez J; Duarte J
    J Hypertens; 2015 Sep; 33(9):1831-44. PubMed ID: 26147382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
    Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
    Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
    Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension.
    Zarzuelo MJ; Gómez-Guzmán M; Jiménez R; Quintela AM; Romero M; Sánchez M; Zarzuelo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
    Cardiovasc Res; 2013 Sep; 99(4):622-31. PubMed ID: 23752977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Robles-Vera I; Tamargo J; Martínez MC; Pérez-Vizcaíno F; Duarte J
    Biochem Pharmacol; 2016 Jun; 110-111():25-36. PubMed ID: 27179975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5.
    Romero M; Jiménez R; Toral M; León-Gómez E; Gómez-Gúzman M; Sánchez M; Zarzuelo MJ; Rodríguez-Gómez I; Rath G; Tamargo J; Pérez-Vizcaíno F; Dessy C; Duarte J
    J Pharmacol Exp Ther; 2016 Jul; 358(1):151-63. PubMed ID: 27189971
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Toral M; Robles-Vera I; Romero M; de la Visitación N; Sánchez M; O'Valle F; Rodriguez-Nogales A; Gálvez J; Duarte J; Jiménez R
    FASEB J; 2019 Sep; 33(9):10005-10018. PubMed ID: 31173526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.
    Kapoor A; Shintani Y; Collino M; Osuchowski MF; Busch D; Patel NS; Sepodes B; Castiglia S; Fantozzi R; Bishop-Bailey D; Mota-Filipe H; Yaqoob MM; Suzuki K; Bahrami S; Desvergne B; Mitchell JA; Thiemermann C
    Am J Respir Crit Care Med; 2010 Dec; 182(12):1506-15. PubMed ID: 20693380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats.
    Zarzuelo MJ; Jiménez R; Galindo P; Sánchez M; Nieto A; Romero M; Quintela AM; López-Sepúlveda R; Gómez-Guzmán M; Bailón E; Rodríguez-Gómez I; Zarzuelo A; Gálvez J; Tamargo J; Pérez-Vizcaíno F; Duarte J
    Hypertension; 2011 Oct; 58(4):733-43. PubMed ID: 21825230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation.
    Toral M; Romero M; Pérez-Vizcaíno F; Duarte J; Jiménez R
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H189-H200. PubMed ID: 27881385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.
    Capozzi ME; McCollum GW; Savage SR; Penn JS
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4197-207. PubMed ID: 23716627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist on systemic inflammation after haemorrhagic shock.
    Yin L; Busch D; Qiao Z; van Griensven M; Teuben M; Hildebrand F; Pape HC; Pfeifer R
    Cytokine; 2018 Mar; 103():127-132. PubMed ID: 28969938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury.
    Qian B; Wang C; Li X; Ma P; Dong L; Shen B; Wu H; Li N; Kang K; Ma Y
    Liver Int; 2023 Dec; 43(12):2808-2823. PubMed ID: 37833850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
    Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
    Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
    Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
    Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed activation of PPAR-β/δ improves long-term survival in mouse sepsis: effects on organ inflammation and coagulation.
    Busch D; Kapoor A; Rademann P; Hildebrand F; Bahrami S; Thiemermann C; Osuchowski MF
    Innate Immun; 2018 May; 24(4):262-273. PubMed ID: 29697010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.